GSG (GSGG) 10-K2 Jul 242023 FY Annual reportFinancial data

Company Profile

Cover

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2023	Jun. 28, 2024	Jun. 30, 2023
Cover [Abstract]
Entity Registrant Name	GSG GROUP INC.
Entity Central Index Key	0001668523
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		37,415,902
Entity Public Float			$ 0
Document Annual Report	true
Document Transition Report	false
Document Fin Stmt Error Correction Flag	false
Entity File Number	333-209903
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	37-1769300
Entity Address Address Line 1	Flat 8-9, 5/F, Wing On Plaza
Entity Address Address Line 2	62 Mody Road
Entity Address Address Line 3	Tsim Sha Tsui
Entity Address City Or Town	KLN
Entity Address Country	HK
Entity Address Postal Zip Code	8808
City Area Code	852
Local Phone Number	3106 8189
Entity Interactive Data Current	Yes
Auditor Name	JTC Fair Song CPA Firm
Auditor Firm Id	2747
Auditor Location	Shenzhen, China

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash	$ 200	$ 200
Inventory	0	0
Trade and other receivables	0	0
Prepaid expenses	0	0
Total Current Assets	200	0
Property and equipment, net	0	0
Total Assets	200	200
Current Liabilities
Accrued expenses and other payables	43,619	36,195
Due to related parties	87,506	78,106
Total Current Liabilities	131,125	114,301
Total Liabilities	131,125	114,301
Common stock - par value $0.001; 75,000,000 shares authorized, 55,125,000 shares issued and outstanding as of December 31, 2023 (75,000,000 shares authorized, 30,125,000 shares issued and outstanding as of December 31, 2022)	55,125	30,125
Additional paid-in capital	0	18,261
Accumulated deficit	(186,050)	(162,487)
Total Stockholders' Deficit	(130,925)	(114,101)
Total Liabilities and Stockholders' Deficit	$ 200	$ 200

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
BALANCE SHEETS
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	55,125,000	30,125,000
Common stock, shares outstanding	55,125,000	30,125,000

STATEMENTS OF OPERATIONS (Unaud

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	12 Months Ended
STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
STATEMENTS OF OPERATIONS (Unaudited)
Revenues	$ 0	$ 0
Cost of goods sold	0	0
Gross profit	0	0
Operating expenses:
General and administrative expenses	(16,824)	(16,076)
Total operating expenses	(16,824)	(16,076)
Share issuance cost	(6,739)	0
Total other expenses	(6,739)	0
Loss before provision for income taxes	(23,563)	(16,076)
Provision for income taxes	0	0
Net loss	$ (23,563)	$ (16,076)
Net loss per share
Basic and diluted	$ 0	$ 0
Weighted average shares outstanding
Basic and diluted	41,563,356	30,125,000

STATEMENTS OF CASH FLOWS (Unaud

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	12 Months Ended
STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (23,563)	$ (16,076)
Depreciation expense	0	0
Share issuance cost	6,739	0
Changes in operating assets and liabilities:
Prepaid expenses & deposits	0	0
Accrued expenses and other payables	7,424	2,576
Accounts payable	0	0
CASH FLOWS USED IN OPERATING ACTIVITIES	(9,400)	(13,500)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sales of common stock	0	0
Proceeds from related parties	9,400	13,500
Repayments to related parties	0	0
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	9,400	13,500
NET INCREASE IN CASH	0	0
Cash, beginning of period	200	200
Cash, end of period	$ 200	200
NON-CASH TRANSACTIONS:
Forgiveness of net liabilities by former shareholder		0
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Interest paid		0
Income taxes paid		$ 0

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2021		30,125,000
Balance, amount at Dec. 31, 2021	$ (98,025)	$ 30,125	$ 18,261	$ (146,411)
Net loss for the year ended December 31, 2022	(16,076)	$ 0	0	(16,076)
Balance, shares at Dec. 31, 2022		30,125,000
Balance, amount at Dec. 31, 2022	(114,101)	$ 30,125	18,261	(162,487)
Net loss for the year ended December 31, 2022	(23,563)	$ 0	0	(23,563)
25,000,000 shares issued at par value of $0.001 per share as per SEA on July 17, 2023, shares		25,000,000
25,000,000 shares issued at par value of $0.001 per share as per SEA on July 17, 2023, amount	6,739	$ 25,000	(18,261)	0
Balance, shares at Dec. 31, 2023		55,125,000
Balance, amount at Dec. 31, 2023	$ (130,925)	$ 55,125	$ 0	$ (186,050)

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
Organization and Basis of Presentation	Dec. 31, 2023
Organization and Basis of Presentation
Organization and Basis of Presentation	Note 1: Organization and Basis of Presentation GSG Group Inc. (the “Company”) is a for-profit corporation established under the corporate laws of the State of Nevada on November 11, 2014. Initially, we were a development-stage company in the ornamental ribbons printing business. On April 6, 2017, we changed the business to consulting services for investors in the Asian real estate market and other growth industries. On September 15, 2017, the name change to GSG Group Inc. was approved by the Financial Industry Regulatory Authority ("FINRA") and the Company began discussions to add Medical Devices production and trading to its business portfolio. Since January 1st, 2023 the Company has its office at Churerstrasse 47, 8808 Pfäffikon, Schwyz, Switzerland. As of May 25, 2023 and following Management having revised the business plan of the Company and implementation of the Prejex project no longer being its first priority, the Asset Assignment Agreement with Prejex Holding GmbH was cancelled in mutual consent by the parties. On July 17, 2023, the Company added two new directors, Ms. Wenqiu Liao and Mr. Ha Leong Lau to the Company’s Board. On July 17, 2023, the Company entered into a Share Exchange Agreement (the “SEA”) with Kingdom Defi Limited to its 100% interest in Harmony Physiotherapy Limited (the “Predecessor Company”)’s operations of professional physiotherapy treatment and healthcare services. On July 18, 2023, the President and CEO position of Mr. Maarten Stuut was replaced by Ms. Wenqiu Liao. The CFO position of Mr. Maarten Stuut was replaced by Mr. Ha Leong Lau as the Acting CFO of the Company. The Acting CFO shall serve in this role until a permanent CFO is appointed. The COO position of Mr. Chester Jansen was replaced that day by Mr. Po Hei Chan and Mr. Stuut and Mr. Jansen left the board. On July 19, 2023, the Company cancelled the shares of Mr. Gim Hooi Ooi, a shareholder of the Company, and reversed the aged debt of $40,323 owing to Mr. Gim Hooi Ooi. Mr. Gim Hooi Ooi held a total of 17,709,098 common shares of the Company which was equivalent to an aggregate of 58.78% of outstanding and issued shares prior to the cancellation. The cancellation of the 17,709,098 common shares of the Company held by Mr. Gim Hooi Ooi was subsequently completed on June 28, 2024. On July 19, 2023, the Company issued 25,000,000 common shares to Kingdom Defi Limited as per the SEA in exchange for a new business into the Company. The new share issuance was completed on August 18, 2023. The Company also has its new office at Flat 8-9, 5/F, Wing On Plaza, 62 Mody Road, Tsim Sha Tsui, KLN, Hong Kong. Following the addition of new directors and management to the board, the extended management prepared and presented its revised business plan for the Company with its focus returning to Asia and the rising needs of China, one of the highest populated countries and thus biggest markets in the world. The new business potentially will generate a healthy stream of new income to the Company. The management has primarily targeted a physiotherapy company with 15 years of experience in the industry, specifically targeting the elderly with physiotherapy needs, fitness enthusiasts, athletes, and individuals seeking injury prevention and recovery.

GOING CONCERN

GOING CONCERN	12 Months Ended
GOING CONCERN	Dec. 31, 2023
GOING CONCERN
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate the continuation of the Company as a going concern. However, the Company had no revenue for the year ended December 31, 2023 and incurred recurring losses. In addition, the Company had negative working capital and generated negative cash flows from operating activities for the year ended December 31, 2023, and has not completed its efforts to establish a stable source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on borrowings from related parties to fund operating expenses. In light of management’s efforts, there are no assurances that the Company will be successful in any of its endeavors or become financially viable and continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for financial information. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the year ended December 31, 2023 included in the Company’s Form 10-K filed with the Securities and Exchange Commission. The unaudited interim financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the year ended December 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. Use of Estimates and Assumptions The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern. Fair Value of Financial Instruments ASC topic 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying amounts of cash, prepaid expenses and accrued expenses and other payables approximate their fair value due to their relatively short-term maturity. Related Party Transaction A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. The Company conducts business with its related parties in the ordinary course of business. Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated. Revenue Recognition The Company will recognize revenue in accordance with ASC topic 605 “Revenue Recognition”. Revenue is recognized when the four basic criteria of revenue recognition are met: (1) a contractual agreement exists; (2) transfer of rights has been completed; (3) the fee is fixed or determinable; and (4) collectability is reasonably assured. The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2023
Related Party Transactions
Related Party Transactions	NOTE 4 – Related Party Transactions During the year ended December 31, 2023, the Company borrowed cash of $9,400 from a major shareholder for operating purposes and repaid in the amount of $0. During the year ended December 31, 2022, the Company had borrowed cash of $9,000 from its directors or other related parties for operating purposes and had repaid in the amount of $0. During the year ended December 3, 2023, the directors or other related parties paid operating expenses of $0 on behalf of the Company and the Company repaid in the amount of $0. The borrowings from and expenses paid by directors or other related parties are unsecured, non-interest bearing, and due on demand.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 5 – COMMITMENTS AND CONTINGENCIES None

The Share Exchange Agreement (S

The Share Exchange Agreement (SEA)	12 Months Ended
The Share Exchange Agreement (SEA)	Dec. 31, 2023
The Share Exchange Agreement (SEA)
The Share Exchange Agreement (SEA)	NOTE 6 – The Share Exchange Agreement (SEA) On July 17, 2023, the Company entered into a Share Exchange Agreement (the “SEA”) with Kingdom Defi Limited in relation to its 100% interest in Harmony Physiotherapy Limited (the “Predecessor Company”)’s operations of professional physiotherapy treatment and healthcare services. On July 19, 2023, the Company issued 25,000,000 common shares to Kingdom Defi Limited as per the SEA in exchange for a new business into the Company. However, the Predecessor Company was unable to deliver their audited financial statements as of December 31, 2023 due to delays from the Predecessor Company’s accountants. Therefore, the closing of the SEA was mutually agreed to further postponed to July 31, 2024, and the 25,000,000 common shares issued were recorded at par value with debit to Additional Paid-in Capital and excess charged to Other Expenses – Share Issuance Cost. The Company expects to take over Harmony Medical Group Limited (the “Successor Company”), a dormant company incorporated in Hong Kong on March 8, 2023 before July 31, 2024 to carry out the operations of The Predecessor Company. Therefore, we will cease to be a shell in July 2024, after the Successor Company has taken over the operations of the Predecessor Company. The Company will incorporate the net asset value of the Successor Company into the Company’s books against Additional Paid-in Capital. The new share issuance was completed on August 18, 2023. On March 6, 2024, The Predecessor Company’s auditor signed off on the Predecessor Company’s financial statements for the two years ended March 31, 2023 and 2022. A summary of key financial figures and additional information is provided in Note – 7, Subsequent Events.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 7 – SUBSEQUENT EVENTS Messrs. Value Plus CPA limited, Certified Public Accountants (Practicing) have audited the financial statements of Harmony Physiotherapy Limited, the Predecessor Company, which comprise the statement of financial position as of March 31, 2023 and 2022, and the income statements for the two years then ended, and notes to the financial statements, including a summary of significant accounting policies. In their opinion, the financial statements of the Predecessor Company are prepared, in all material respects, in accordance with Hong Kong Small and Medium-sized Entity Financial Reporting Standard (“SME-FRS”) issued by the Hong Kong Institute of Certified Public Accountants (“HKICPA”) and have been properly prepared in compliance with the Hong Kong Companies Ordinance. They conducted their audits in accordance with Hong Kong Standards on Auditing (“HKSAs”) and with reference to Practice Note 900 (Revised), Audit of Financial Statements Prepared in Accordance with the Small and Medium-sized Entity Financial Reporting Standard issued by the HKICPA. The following is a summary of key financial figures of the Predecessor Company: Income Statement For the Years Ended March 31, 2023 2022 (HKD) (HKD) Revenues $ 2,188,034 $ 1,186,542 Direct Cost (19,348 ) (164,494 ) Gross Profit 2,168,686 1,022,048 Other Revenues 61,025 - Administrative Expenses (3,785,113 ) (1,329,824 ) Loss Before Tax and Interest (1,555,402 ) (307,776 ) Statement of Financial Position As of March 31, 2023 2022 (HKD) (HKD) Assets Non-Current Asset Property, Plant and Equipment 191,218 246,489 Total Non-Current Asset 191,218 246,489 Current Assets Cash and Cash Equivalents 45,110 3,855 Total Current Assets 45,110 3,855 Total Assets 236,328 250,344 Liabilities Current Liabilities Accrued Expenses 21,000 10,500 Total Liabilities 21,000 10,500 Net Assets 215,328 239,844 We expect to takeover Harmony Medical Group Limited (the “Successor Company”), a dormant company incorporated in Hong Kong on March 8, 2023 before July 31, 2024, to carry out the operations of the Predecessor Company. Therefore, we will cease to be a shell in July 2024, after the Successor Company has taken over the operations of the Predecessor Company. For more information, please visit our website www.gsggpro.com On July 19, 2023, the Company cancelled the shares of Mr. Gim Hooi Ooi, a shareholder of the Company, and reversed the aged debt of $40,323 owing to Mr. Gim Hooi Ooi. Mr. Gim Hooi Ooi held a total of 17,709,098 common shares of the Company which was equivalent to an aggregate of 58.78% of outstanding and issued shares prior to the cancellation. The cancellation of the 17,709,098 common shares of the Company held by Mr. Gim Hooi Ooi was subsequently completed on June 28, 2024.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for financial information. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the year ended December 31, 2023 included in the Company’s Form 10-K filed with the Securities and Exchange Commission. The unaudited interim financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the year ended December 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023.
Use of Estimates and Assumptions	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.
Fair Value of Financial Instruments	ASC topic 820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying amounts of cash, prepaid expenses and accrued expenses and other payables approximate their fair value due to their relatively short-term maturity.
Related Party Transaction	A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. The Company conducts business with its related parties in the ordinary course of business. Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.
Revenue Recognition	The Company will recognize revenue in accordance with ASC topic 605 “Revenue Recognition”. Revenue is recognized when the four basic criteria of revenue recognition are met: (1) a contractual agreement exists; (2) transfer of rights has been completed; (3) the fee is fixed or determinable; and (4) collectability is reasonably assured. The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

SUBSEQUENT EVENTS (Tables)

SUBSEQUENT EVENTS (Tables)	12 Months Ended
SUBSEQUENT EVENTS (Tables)	Dec. 31, 2023
SUBSEQUENT EVENTS
Summary of Income Statement	Income Statement For the Years Ended March 31, 2023 2022 (HKD) (HKD) Revenues $ 2,188,034 $ 1,186,542 Direct Cost (19,348 ) (164,494 ) Gross Profit 2,168,686 1,022,048 Other Revenues 61,025 - Administrative Expenses (3,785,113 ) (1,329,824 ) Loss Before Tax and Interest (1,555,402 ) (307,776 )
Summary of Statement of Financial Position	Statement of Financial Position As of March 31, 2023 2022 (HKD) (HKD) Assets Non-Current Asset Property, Plant and Equipment 191,218 246,489 Total Non-Current Asset 191,218 246,489 Current Assets Cash and Cash Equivalents 45,110 3,855 Total Current Assets 45,110 3,855 Total Assets 236,328 250,344 Liabilities Current Liabilities Accrued Expenses 21,000 10,500 Total Liabilities 21,000 10,500 Net Assets 215,328 239,844

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details Narrative)	1 Months Ended
Organization and Basis of Presentation (Details Narrative)	Jul. 19, 2023 USD ($) shares
Mr. Gim Hooi Ooi
Reversed debt \| $	$ 40,323
Shares Cancelled	17,709,098
Total common shares held	17,709,098
Kingdom Defi Limited
Stock issud during period in exchange for a business	25,000,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	12 Months Ended
	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of related party transaction	(i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
Related Party Transactions (Details Narrative) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Borrowed cash	$ 9,400	$ 9,000
Opertaing expense paid to related party	0
Repaid received from company	0	$ 0
Directors [Member]
Opertaing expense paid to related party	$ 0

The Share Exchange Agreement _2

The Share Exchange Agreement (SEA) (Details Narrative)	1 Months Ended
The Share Exchange Agreement (SEA) (Details Narrative)	Jul. 19, 2023 shares
Kingdom Defi Limited
Stock issud during period in exchange for a business	25,000,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)	12 Months Ended
SUBSEQUENT EVENTS (Details)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 HKD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 HKD ($)
Revenues	$ 0		$ 0
Gross Profit	$ 0		$ 0
Income Statement
Revenues		$ 2,188,034		$ 1,186,542
Direct Cost		(19,348)		(164,494)
Gross Profit		2,168,686		1,022,048
Other Revenues		61,025		0
Administrative Expenses		(3,785,113)		(1,329,824)
Loss Before Tax and Interest		$ (1,555,402)		$ (307,776)

SUBSEQUENT EVENTS (Details 1)

SUBSEQUENT EVENTS (Details 1)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2023 HKD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)
Non-Current Asset
Property, Plant and Equipment	$ 0			$ 0
Current Assets
Total Current Assets	200			0
Total Assets	200			200
Current Liabilities
Total Liabilities	$ 131,125			$ 114,301
Statement of Financial Position
Non-Current Asset
Property, Plant and Equipment			$ 191,218		$ 246,489
Total Non-Current Asset		$ 191,218			246,489
Current Assets
Cash and Cash Equivalents		45,110			3,855
Total Current Assets		45,110			3,855
Total Assets		236,328			250,344
Current Liabilities
Accrued Expenses		21,000			10,500
Total Liabilities		21,000			10,500
Net Assets		$ 215,328			$ 239,844

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Mr. Gim Hooi Ooi	1 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - Mr. Gim Hooi Ooi	Jul. 19, 2023 USD ($) shares
Reversed debt \| $	$ 40,323
Total common shares held	17,709,098
Shares Cancelled	17,709,098